Literature DB >> 25564679

Serum Uric Acid, Gender, and Low Ankle Brachial Index in Adults With High Cardiovascular Risk.

Yiqiang Zhan1, Ying Dong2, Zheng Tang1, Fen Zhang3, Dayi Hu4, Jinming Yu5.   

Abstract

Uric acid (UA) has been reported to be associated with cardiovascular disease (CVD) in caucasians. However, it is unclear whether this association remains significant in a Chinese population. The present study aimed to investigate the association between UA and low ankle brachial index (ABI), a measurement of peripheral arterial disease, in Chinese patients. A total of 6262 hospital-based patients with high CVD risk were enrolled. Low ABI was defined as ABI ≤0.9 in either side. Low ABI was detected in 1390 (22.2%) patients. Higher UA was significantly associated with higher risk of low ABI and modified by gender (P = .0045). After adjusting for age, body mass index, total cholesterol, triglyceride, low-density lipoprotein, high-density lipoprotein, fasting glucose, hypertension, and smoking, participants in the highest quartile of UA exhibited 37% (odds ratio [OR]:1.37, 95% confidence interval [CI]: 1.03-1.82) higher risk of low ABI compared to those in the lowest quartile in men, while OR (95% CI) was 1.69 (1.29-2.22) for women. However, when kidney function was further adjusted, the associations were attenuated in both men and women and were significant only in women. The results were suggestive of higher UA associating with higher risk of low ABI in women, and the association was largely driven by kidney function, especially in men.
© The Author(s) 2015.

Entities:  

Keywords:  ankle brachial index; gender differences; peripheral arterial disease; uric acid

Mesh:

Substances:

Year:  2015        PMID: 25564679     DOI: 10.1177/0003319714566228

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

1.  Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.

Authors:  Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

2.  Association of overweight and obesity with cardiovascular risk factors in patients with atherosclerotic diseases.

Authors:  Milos Maksimovic; Hristina Vlajinac; Djordje Radak; Jelena Marinkovic; Jadranka Maksimovic; Jagoda Jorga
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

3.  Complex nonlinear autonomic nervous system modulation link cardiac autonomic neuropathy and peripheral vascular disease.

Authors:  Kinda Khalaf; Herbert F Jelinek; Caroline Robinson; David J Cornforth; Mika P Tarvainen; Hayder Al-Aubaidy
Journal:  Front Physiol       Date:  2015-03-27       Impact factor: 4.566

4.  A Prediction Model for the Peripheral Arterial Disease Using NHANES Data.

Authors:  Yang Zhang; Jinxing Huang; Ping Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Incidence of Peripheral Arterial Disease and Its Association with Pulse Pressure: A Prospective Cohort Study.

Authors:  Yong Mao; Yixiang Huang; Haining Yu; Peng Xu; Guangping Yu; Jinming Yu; Yiqiang Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-24       Impact factor: 5.555

6.  Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease.

Authors:  Tai-Hua Chiu; Pei-Yu Wu; Jiun-Chi Huang; Ho-Ming Su; Szu-Chia Chen; Jer-Ming Chang; Hung-Chun Chen
Journal:  Diagnostics (Basel)       Date:  2020-07-24

7.  Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study.

Authors:  Huan Liu; Jinbo Liu; Hongwei Zhao; Yingyan Zhou; Lihong Li; Hongyu Wang
Journal:  J Atheroscler Thromb       Date:  2017-09-12       Impact factor: 4.928

8.  Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study.

Authors:  V Cornejo Del Río; J Mostaza; C Lahoz; V Sánchez-Arroyo; C Sabín; S López; P Patrón; P Fernández-García; B Fernández-Puntero; D Vicent; L Montesano-Sánchez; F García-Iglesias; T González-Alegre; E Estirado; F Laguna; C de Burgos-Lunar; P Gómez-Campelo; J C Abanades-Herranz; J M de Miguel-Yanes; M A Salinero-Fort
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.